Bimzelx 160 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FRWTX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $84,391
Award facts
- Contract value 100% obligated
- $84,390.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $84,390.90 delivery order to AmerisourceBergen Drug Corp on May 7, 2025, for the supply of Bimzelx 160 mg/mL auto-injector medication. This firm fixed-price delivery order, with an ultimate completion date of May 8, 2025, was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and broader military healthcare systems. The company's extensive portfolio of federal contracts demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Bimzelx, a specialized biologic therapy, reflects the contractor's role in supplying advanced pharmaceutical solutions to support Department of Defense medical operations and personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FRWTX?
SPE2DB25FRWTX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 7, 2025.
How much is contract SPE2DB25FRWTX worth?
The government has obligated $84,391 on SPE2DB25FRWTX.
Is contract SPE2DB25FRWTX an order under another contract?
Yes. SPE2DB25FRWTX is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRWTX competed?
The extent of competition for SPE2DB25FRWTX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award